🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 7 Days
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(529)
All (529)
Buys (31)
Sells (498)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Teladoc Health, Inc.
(TDOC)
Bliss Kelly
— President, U.S. Group Health
Jul 1, 2026
Sale
Shares
2,500
Price
$9.00
Total Value
$22.50K
Shares Held After
87,378
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
American Well Corp
(AMWL)
Gotlib Phyllis
— President, International
Jul 1, 2026
Sale
Shares
6,677
Price
$9.33
Total Value
$62.30K
Shares Held After
152,754
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
American Well Corp
(AMWL)
HIRSCHHORN MARK
— Chief Financial Officer
Jul 1, 2026
Sale
Shares
4,299
Price
$9.33
Total Value
$40.11K
Shares Held After
238,939
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
American Well Corp
(AMWL)
Zamansky Dmitry
— Chief Product & Tech. Officer
Jul 1, 2026
Sale
Shares
8,460
Price
$9.33
Total Value
$78.93K
Shares Held After
232,620
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
American Well Corp
(AMWL)
McNeice Paul Francis
— Chief Accounting Officer
Jul 1, 2026
Sale
Shares
653
Price
$9.33
Total Value
$6.09K
Shares Held After
9,851
% of Holdings
6.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
KONOWIECKI JOSEPH S
— Director
Jul 1, 2026
Sale
Shares
25,000
Price
$24.00
Total Value
$600.00K
Shares Held After
1,103,816
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Ng George K
— Director
Jul 1, 2026
Purchase
Shares
3,057
Price
$1.93
Total Value
$5.90K
Shares Held After
15,492
% of Holdings
19.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Camblong Jurgi
— Director
Jun 30, 2026
Sale
Shares
200
Price
$6.30
Total Value
$1.26K
Shares Held After
3,581,293
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Camblong Jurgi
— Director
Jun 30, 2026
Sale
Shares
19,650
Price
$6.02
Total Value
$118.32K
Shares Held After
3,581,493
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Camblong Jurgi
— Director
Jun 30, 2026
Sale
Shares
45,419
Price
$6.14
Total Value
$279.05K
Shares Held After
3,601,143
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tectonic Therapeutic, Inc.
(TECX)
McNamara Peter
— Chief Scientific Officer
Jun 30, 2026
Sale
Shares
172
Price
$35.00
Total Value
$6.02K
Shares Held After
55,285
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Beam Therapeutics Inc.
(BEAM)
Evans John M.
— Director
Jun 30, 2026
Sale
Shares
1,900
Price
$34.84
Total Value
$66.20K
Shares Held After
1,047,205
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Beam Therapeutics Inc.
(BEAM)
Evans John M.
— Director
Jun 30, 2026
Sale
Shares
23,100
Price
$34.26
Total Value
$791.48K
Shares Held After
1,049,105
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ImmunityBio, Inc.
(IBRX)
Selecky Christobel
— Director
Jun 30, 2026
Sale
Shares
1,000
Price
$9.00
Total Value
$9.00K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Monte Rosa Therapeutics, Inc.
(GLUE)
Janku Filip
— Chief Medical Officer
Jun 30, 2026
Sale
Shares
5,407
Price
$24.50
Total Value
$132.47K
Shares Held After
60,612
% of Holdings
8.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
240
Price
$549.27
Total Value
$131.82K
Shares Held After
40,513
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
14
Price
$546.60
Total Value
$7.65K
Shares Held After
40,753
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
66
Price
$545.96
Total Value
$36.03K
Shares Held After
40,767
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
440
Price
$543.30
Total Value
$239.05K
Shares Held After
40,833
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
1,081
Price
$542.62
Total Value
$586.57K
Shares Held After
41,273
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
2,499
Price
$541.60
Total Value
$1.35M
Shares Held After
42,354
% of Holdings
5.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
2,235
Price
$540.76
Total Value
$1.21M
Shares Held After
44,853
% of Holdings
4.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
1,309
Price
$539.93
Total Value
$706.77K
Shares Held After
47,088
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
988
Price
$538.51
Total Value
$532.04K
Shares Held After
48,397
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
518
Price
$537.75
Total Value
$278.55K
Shares Held After
49,385
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Jun 30, 2026
Sale
Shares
110
Price
$536.28
Total Value
$58.99K
Shares Held After
49,903
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Guy Wendy
— Chief Administrative Officer
Jun 30, 2026
Purchase
Shares
2,436
Price
$1.93
Total Value
$4.70K
Shares Held After
14,394
% of Holdings
16.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Gault Cheryl
— Chief Operating Officer
Jun 30, 2026
Sale
Shares
1,000
Price
$43.15
Total Value
$43.15K
Shares Held After
149,914
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Gault Cheryl
— Chief Operating Officer
Jun 30, 2026
Sale
Shares
3,308
Price
$42.17
Total Value
$139.51K
Shares Held After
150,914
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Gault Cheryl
— Chief Operating Officer
Jun 30, 2026
Sale
Shares
3,792
Price
$41.39
Total Value
$156.96K
Shares Held After
154,222
% of Holdings
2.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Rapport Therapeutics, Inc.
(RAPP)
Gault Cheryl
— Chief Operating Officer
Jun 30, 2026
Sale
Shares
1,900
Price
$40.09
Total Value
$76.17K
Shares Held After
158,014
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oscar Health, Inc.
(OSCR)
Bertolini Mark T
— Director
Jun 30, 2026
Sale
Shares
135,590
Price
$28.97
Total Value
$3.93M
Shares Held After
7,751,570
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oscar Health, Inc.
(OSCR)
Bertolini Mark T
— Director
Jun 30, 2026
Sale
Shares
488,654
Price
$28.35
Total Value
$13.85M
Shares Held After
7,887,160
% of Holdings
5.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Young David
— Director
Jun 30, 2026
Purchase
Shares
2,531
Price
$1.93
Total Value
$4.88K
Shares Held After
21,729
% of Holdings
11.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
SKIBSTED RUSSELL
— Chief Financial Officer
Jun 30, 2026
Purchase
Shares
3,277
Price
$1.93
Total Value
$6.32K
Shares Held After
16,689
% of Holdings
19.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioAge Labs, Inc.
(BIOA)
Barton Shane
— Principal Accounting Officer
Jun 30, 2026
Sale
Shares
20,216
Price
$25.19
Total Value
$509.18K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zai Lab Ltd
(ZLAB)
Du Ying
— Director
Jun 30, 2026
Sale
Shares
7,026
Price
$18.53
Total Value
$130.22K
Shares Held After
1,203,784
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Processa Pharmaceuticals, Inc.
(PCSA)
Lin Patrick
— Chief Business - Strategy Off
Jun 30, 2026
Purchase
Shares
2,106
Price
$1.93
Total Value
$4.06K
Shares Held After
13,113
% of Holdings
16.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
X4 Pharmaceuticals, Inc
(XFOR)
KIRSKE DAVID
— Chief Financial Officer
Jun 30, 2026
Sale
Shares
8,543
Price
$4.26
Total Value
$36.43K
Shares Held After
167,750
% of Holdings
4.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvectis Pharma, Inc.
(NVCT)
Mosseri Marlio Charles
— 10% Owner
Jun 30, 2026
Purchase
Shares
50,000
Price
$18.32
Total Value
$916.00K
Shares Held After
3,186,576
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nuvectis Pharma, Inc.
(NVCT)
BENTSUR RON
— Director
Jun 30, 2026
Purchase
Shares
12,500
Price
$20.00
Total Value
$250.00K
Shares Held After
3,688,424
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alpha Tau Medical Ltd.
(DRTS)
Levy Raphi
— Chief Financial Officer
Jun 30, 2026
Sale
Shares
20,000
Price
$12.00
Total Value
$240.04K
Shares Held After
90,180
% of Holdings
18.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Roivant Sciences Ltd.
(ROIV)
MANCHESTER KEITH S
— Director
Jun 30, 2026
Sale
Shares
200,000
Price
$35.45
Total Value
$7.09M
Shares Held After
1,748,403
% of Holdings
10.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Roivant Sciences Ltd.
(ROIV)
MANCHESTER KEITH S
— Director
Jun 30, 2026
Sale
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Roivant Sciences Ltd.
(ROIV)
Gold Daniel Allen
— Director
Jun 30, 2026
Sale
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Roivant Sciences Ltd.
(ROIV)
QVT Financial LP
— Director by Deputization
Jun 30, 2026
Sale
Shares
12,380
Price
$35.28
Total Value
$436.77K
Shares Held After
13,689,166
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Edwards Lifesciences Corp
(EW)
Lippis Daniel J.
— CVP, TAVR
Jun 30, 2026
Sale
Shares
619
Price
$91.40
Total Value
$56.58K
Shares Held After
40,411
% of Holdings
1.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mineralys Therapeutics, Inc.
(MLYS)
Congleton Jon
— Director
Jun 30, 2026
Sale
Shares
17,000
Price
$26.82
Total Value
$455.90K
Shares Held After
614,321
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Mineralys Therapeutics, Inc.
(MLYS)
Congleton Jon
— Director
Jun 30, 2026
Sale
Shares
58,000
Price
$25.94
Total Value
$1.50M
Shares Held After
631,321
% of Holdings
8.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Camblong Jurgi
— Director
Jun 29, 2026
Sale
Shares
350
Price
$6.00
Total Value
$2.10K
Shares Held After
3,601,143
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Next →
Showing 1–50 of 529 transactions (page 1 of 11)
Version: v26.5.2